Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals

Plant Biotechnology Journal

Volumn 13, Issue 8, 2015, Pages 1180-1190

  Holtz, Barry R ^a   Berquist, Brian R ^a   Bennett, Lindsay D ^a   Kommineni, Vally J M ^a   Munigunti, Ranjith K ^a   White, Earl L ^a   Wilkerson, Don C ^a   Wong, Kah Yat I ^a   Ly, Lan H ^a   Marcel, Sylvain ^a  

^a Caliber Biotherapeutics   (United States)

Author keywords

Nicotiana benthamiana; Manufacturing; Monoclonal antibodies; Plant made pharmaceuticals; Transient expression; Vaccine

Indexed keywords

DRUG; MONOCLONAL ANTIBODY;

BIOLOGICAL THERAPY; BIOSYNTHESIS; BIOTECHNOLOGY; ECONOMICS; GENETICS; HUMAN; METABOLISM; PLANT; TRANSGENIC PLANT;

ANTIBODIES, MONOCLONAL; BIOLOGICAL THERAPY; BIOTECHNOLOGY; HUMANS; PHARMACEUTICAL PREPARATIONS; PLANTS; PLANTS, GENETICALLY MODIFIED;

EID: 84942155410     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.12469     Document Type: Review

References (30)

1. Bendandi, M., Marillonnet, S., Kandzia, R., Thieme, F., Nickstadt, A., Herz, S., Frode, R., Inoges, S., Lopez-Diaz de Cerio, A., Soria, E., Villanueva, H., Vancanneyt, G., McCormick, A., Tuse, D., Lenz, J., Butler-Ransohoff, J.E., Klimyuk, V. and Gleba, Y. (2010) Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Ann. Oncol. 21, 2420-2427.
2. Cummings, J.F., Guerrero, M.L., Moon, J.E., Waterman, P., Nielsen, R.K., Jefferson, S., Gross, F.L., Hancock, K., Katz, J.M., Yusibov, V. and Fraunhofer, U.S.A.C.f.M.B.S.G (2014) Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults. Vaccine, 32, 2251-2259.
3. De Leede, L.G., Humphries, J.E., Bechet, A.C., Van Hoogdalem, E.J., Verrijk, R. and Spencer, D.G. (2008) Novel controlled-release Lemna-derived IFN-alpha2b (Locteron): pharmacokinetics, pharmacodynamics, and tolerability in a phase I clinical trial. J. Interferon Cytokine Res. 28, 113-122.
4. Giritch, A., Marillonnet, S., Engler, C., van Eldik, G., Botterman, J., Klimyuk, V. and Gleba, Y. (2006) Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc. Natl Acad. Sci. USA, 103, 14701-14706.
5. Gleba, Y., Klimyuk, V. and Marillonnet, S. (2005) Magnifection-a new platform for expressing recombinant vaccines in plants. Vaccine, 23, 2042-2048.
6. Goodin, M.M., Zaitlin, D., Naidu, R.A. and Lommel, S.A. (2008) Nicotiana benthamiana: its history and future as a model for plant-pathogen interactions. Mol. Plant Microbe Interact. 21, 1015-1026.
7. Hiatt, A., Cafferkey, R. and Bowdish, K. (1989) Production of antibodies in transgenic plants. Nature, 342, 76-78.
8. Huang, Z., Phoolcharoen, W., Lai, H., Piensook, K., Cardineau, G., Zeitlin, L., Whaley, K.J., Arntzen, C.J., Mason, H.S. and Chen, Q. (2010) High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnol. Bioeng. 106, 9-17.
9. Jiang, X.R., Song, A., Bergelson, S., Arroll, T., Parekh, B., May, K., Chung, S., Strouse, R., Mire-Sluis, A. and Schenerman, M. (2011) Advances in the assessment and control of the effector functions of therapeutic antibodies. Nat. Rev. Drug Discovery, 10, 101-111.
10. Jornitz, M.W. (2014) The call for agile, flexible facilities: how podular facilities may answer it. Pharma. Process. July/August, 26-27.
11. Laffan, A.M., McKenzie, R., Forti, J., Conklin, D., Marcinko, R., Shrestha, R., Bellantoni, M. and Greenough, W.B. 3rd. (2011) Lactoferrin for the prevention of post-antibiotic diarrhoea. J. Health. Popul. Nutr. 29, 547-551.
12. Landry, N., Ward, B.J., Trepanier, S., Montomoli, E., Dargis, M., Lapini, G. and Vezina, L.P. (2010) Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS ONE, 5, e15559.
13. Landry, N., Pillet, S., Favre, D., Poulin, J.F., Trepanier, S., Yassine-Diab, B. and Ward, B.J. (2014) Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens. Clin. Immunol. 154, 164-177.
14. Marillonnet, S., Thoeringer, C., Kandzia, R., Klimyuk, V. and Gleba, Y. (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat. Biotechnol. 23, 718-723.
15. McCormick, A.A., Reddy, S., Reinl, S.J., Cameron, T.I., Czerwinkski, D.K., Vojdani, F., Hanley, K.M., Garger, S.J., White, E.L., Novak, J., Barrett, J., Holtz, R.B., Tuse, D. and Levy, R. (2008) Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proc. Natl Acad. Sci. USA, 105, 10131-10136.
16. Moore, G.L., Chen, H., Karki, S. and Lazar, G.A. (2010) Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions. MAbs. 2, 181-189.
17. Pastores, G.M., Petakov, M., Giraldo, P., Rosenbaum, H., Szer, J., Deegan, P.B., Amato, D.J., Mengel, E., Tan, E.S., Chertkoff, R., Brill-Almon, E. and Zimran, A. (2014) A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase. Blood Cells Mol. Dis. 53, 253-260.
18. Pogue, G.P., Lindbo, J.A., Garger, S.J. and Fitzmaurice, W.P. (2002) Making an ally from an enemy: plant virology and the new agriculture. Annu. Rev. Phytopathol. 40, 45-74.
19. Pogue, G.P., Vojdani, F., Palmer, K.E., Hiatt, E., Hume, S., Phelps, J., Long, L., Bohorova, N., Kim, D., Pauly, M., Velasco, J., Whaley, K., Zeitlin, L., Garger, S.J., White, E., Bai, Y., Haydon, H. and Bratcher, B. (2010) Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnol. J. 8, 638-654.
20. Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J.B., Fausther-Bovendo, H., Wei, H., Aviles, J., Hiatt, E., Johnson, A., Morton, J., Swope, K., Bohorov, O., Bohorova, N., Goodman, C., Kim, D., Pauly, M.H., Velasco, J., Pettitt, J., Olinger, G.G., Whaley, K., Xu, B., Strong, J.E., Zeitlin, L. and Kobinger, G.P. (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature, 514, 47-53.
21. Rosenberg, Y., Sack, M., Montefiori, D., Forthal, D., Mao, L., Hernandez-Abanto, S., Urban, L., Landucci, G., Fischer, R. and Jiang, X. (2013) Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems. PLoS ONE, 8, e58724.
22. Roy, G., Weisburg, S., Rabindran, S. and Yusibov, V. (2010) A novel two-component Tobacco mosaic virus-based vector system for high-level expression of multiple therapeutic proteins including a human monoclonal antibody in plants. Virology, 405, 93-99.
23. Sainsbury, F., Thuenemann, E.C. and Lomonossoff, G.P. (2009) pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol. J. 7, 682-693.
24. Tacket, C.O., Mason, H.S., Losonsky, G., Estes, M.K., Levine, M.M. and Arntzen, C.J. (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182, 302-305.
25. Thanavala, Y., Mahoney, M., Pal, S., Scott, A., Richter, L., Natarajan, N., Goodwin, P., Arntzen, C.J. and Mason, H.S. (2005) Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl Acad. Sci. USA, 102, 3378-3382.
26. Tusé, D., Ku, N., Bendandi, M., Becerra, C., Collins, R., Langford, N., Sancho, S.I., López-Díaz de Cerio, A., Pastor, F., Kandzia, R., Thieme, F., Jarczowski, F., Krause, D., Ma, J.K.-C., Pandya, S., Klimyuk, V., Gleba, Y. and Butler-Ransohoff, J.E. (2015) Clinical safety and immunogenicity of tumor-targeted, plant-made Id-KLH conjugate vaccines for follicular lymphoma. Biomed. Res. Int. Article ID 648143, in press.
27. Weintraub, J.A., Hilton, J.F., White, J.M., Hoover, C.I., Wycoff, K.L., Yu, L., Larrick, J.W. and Featherstone, J.D. (2005) Clinical trial of a plant-derived antibody on recolonization of mutans streptococci. Caries Res. 39, 241-250.
28. Wirz, H., Sauer-Budge, A.F., Briggs, J., Sharpe, A., Shu, S. and Sharon, A. (2012) Automated production of plant-based vaccines and pharmaceuticals. J. Lab. Autom. 17, 449-457.
29. Yusibov, V., Hooper, D.C., Spitsin, S.V., Fleysh, N., Kean, R.B., Mikheeva, T., Deka, D., Karasev, A., Cox, S., Randall, J. and Koprowski, H. (2002) Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine, 20, 3155-3164.
30. Zimran, A., Gonzalez-Rodriguez, D.E., Abrahamov, A., Elstein, D., Paz, A., Brill-Almon, E. and Chertkoff, R. (2015) Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease. Blood Cells Mol. Dis. 54, 9-16.